Roche issued a press release on its nine month sales with the following headlines. Group sales increase 10% at constant exchange rates and 9% in Swiss francs, due to new products Pharmaceuticals Division sales up 12%, driven by high demand for recently launched medicines, mainly Ocrevus, Hemlibra, Tecentriq and Perjeta Diagnostics Division sales grow 4%, primarily …
Category Archives: 2019Q3
J&J tops estimates
Johnson & Johnson [$JNJ] issued a press release before the market opened on its third quarter results with the following headlines: Sales of $20.7 billion reflecting growth of 1.9%, operational growth of 3.2%* and adjusted operational growth of 5.2%* EPS of $1.81 increased 25.7%; adjusted EPS of $2.12 increased 3.4%* Company increasing Full Year Sales …
UnitedHealth beats estimates and raises outlook
United Healthcare [$UNH] issued a press release on its quarterly results before the market opened with the following headlines: Total Revenues of $60.4 Billion Grew by 7% or $3.8 Billion Year-over-Year Operating Earnings Grew 9% to $5.0 Billion, Including Double-Digit Growth Rates in Each Optum Business Net Earnings Per Share were $3.67, Adjusted Net Earnings …
Continue reading “UnitedHealth beats estimates and raises outlook”